Freeman Ellen W, Sammel Mary D, Liu Li, Gracia Clarisa R, Nelson Deborah B, Hollander Lori
Departments of Obstetrics/Gynecology, University of Pennsylvania School of Medicine, Mudd Suite, 3701 Market Street, Philadelphia, PA 19104-5509, USA.
Arch Gen Psychiatry. 2004 Jan;61(1):62-70. doi: 10.1001/archpsyc.61.1.62.
Associations between depressed mood and hormonal changes during transition to menopause are controversial. To our knowledge, there has been no prospective study of these associations in women commencing when they are premenopausal.
To longitudinally study the associations among reproductive hormones, menopausal status, and other predictors of depressed mood in midlife women.
Cohort study with 6 assessment periods during a 4-year interval. Blood samples were collected 12 times during the follicular phase (days 2-6).
Philadelphia County, Pennsylvania.
A randomly identified, population-based, stratified sample of African American (n = 218) and white (n = 218) women aged 35 to 47 years with regular menstrual cycles, no hormonal or psychotropic medication use, and no serious physical or mental health problems at enrollment.
Center for Epidemiologic Studies Depression Scale score and history of depression via the Primary Care Evaluation of Mental Disorders.
There was an increased likelihood of depressive symptoms during transition to menopause and a decreased likelihood after menopause after adjustment for other predictors of depression, including history of depression, severe premenstrual syndrome, poor sleep, age, race, and employment status (P =.03). The likelihood of depressive symptoms decreased for individuals with a rapidly increasing follicle-stimulating hormone profile (P< or =.001) and also decreased with age compared with premenopausal women (P =.02). Participant aggregate profiles with increasing estradiol levels were significantly associated with depressive symptoms in bivariate analysis (P =.053).
Depressive symptoms as assessed herein increased during transition to menopause and decreased in postmenopausal women. Hormone associations provided corroborating evidence that the changing hormonal milieu contributes to dysphoric mood during transition to menopause.
在向更年期过渡期间,情绪低落与激素变化之间的关联存在争议。据我们所知,尚未有对处于绝经前阶段的女性进行这些关联的前瞻性研究。
纵向研究中年女性生殖激素、绝经状态及其他情绪低落预测因素之间的关联。
队列研究,在4年间隔内进行6次评估。在卵泡期(第2 - 6天)采集12次血样。
宾夕法尼亚州费城县。
从35至47岁、月经周期规律、未使用激素或精神类药物、入组时无严重身体或心理健康问题的非洲裔美国女性(n = 218)和白人女性(n = 218)中随机选取的基于人群的分层样本。
通过精神障碍初级保健评估得出的流行病学研究中心抑郁量表评分及抑郁病史。
在调整了其他抑郁预测因素(包括抑郁病史、严重经前综合征、睡眠不佳、年龄、种族和就业状况)后,向更年期过渡期间出现抑郁症状的可能性增加,而绝经后则降低(P =.03)。促卵泡生成素水平快速升高的个体出现抑郁症状的可能性降低(P≤.001),与绝经前女性相比,随着年龄增长出现抑郁症状的可能性也降低(P =.02)。在双变量分析中,雌二醇水平升高的参与者总体情况与抑郁症状显著相关(P =.053)。
本文评估的抑郁症状在向更年期过渡期间增加,在绝经后女性中减少。激素关联提供了确凿证据,表明激素环境的变化在向更年期过渡期间导致了烦躁情绪。